WallStSmart
ICU

SeaStar Medical Holding Corporation

NASDAQ: ICU · HEALTHCARE · BIOTECHNOLOGY

$4.14
+6.98% today

Updated 2026-04-30

Market cap
$15.22M
P/E ratio
P/S ratio
12.33x
EPS (TTM)
$-5.86
Dividend yield
52W range
$2 – $13
Volume
0.2M

SeaStar Medical Holding Corporation (ICU) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+41.7%
Last 4 quarters
Revenue YoY growth
+526.9%
Most recent quarter
EPS YoY growth
+11.1%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-23.9%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-26$-0.80+21.2%$2.28$2.74+20.2%
2025-11-13$-0.13+61.8%$0.50$0.38-23.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-1.02$-0.80+21.2%$420000.00+526.9%
2025-09-30$-0.34$-0.13+61.8%$183000.00+169.1%
2025-06-30$-0.40$-0.18+55.0%$338000.00
2025-03-31$-0.62$-0.44+29.0%$293000.00
2024-12-31$-0.18$-0.90-400.0%$67000.00
2024-09-30$-1.13$-1.10+2.7%$68000.00
2024-06-30$-1.41$-1.03+27.0%
2024-03-31$-0.15$-0.19-26.7%
2023-12-31$-0.13$-0.22-69.2%
2023-09-30$-0.25$-0.36-44.0%
2023-06-30$-0.25$-0.28-12.0%
2023-03-31$-0.40

Frequently asked questions

Has SeaStar Medical Holding Corporation beaten earnings estimates?
SeaStar Medical Holding Corporation has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +41.7% over the last 4 quarters.
How does ICU stock react to earnings?
ICU stock has moved an average of -1.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is SeaStar Medical Holding Corporation's revenue growth rate?
SeaStar Medical Holding Corporation reported year-over-year revenue growth of +526.9% in its most recent quarter, with EPS growing +11.1% year-over-year.